Forte Biosciences
- Pharmaceutical Preparations
- Dallas, Texas
Compensation history
Top executives at Forte Biosciences received an average of $2M per person in annual compensation from 2016 to 2023.
Average pay of disclosed executives at Forte Biosciences
By year
Executives
We found seven executives who work or worked at Forte Biosciences.
Paul Wagner
Forte Biosciences
Chief Executive Officer
Antony Riley
Forte Biosciences
Chief Financial Officer
Marty Duvall
Forte Biosciences
Chief Executive Officer
Mark Foletta
Forte Biosciences
Chief Financial Officer
Martin Duvall
Forte Biosciences
Chief Executive Officer
Douglas Jolly
Forte Biosciences
Executive Vice President, Research and Pharmaceutical Development
Asha Das
Forte Biosciences
Chief Medical Officer
News
Forte Biosciences CEO Paul Wagner's 2023 pay rises 18% to $1.5M
December 31, 2024
Forte Biosciences CEO Paul Wagner's 2021 pay jumps 597% to $5.4M
April 29, 2022
Forte Biosciences CEO Marty Duvall's 2020 pay falls 34% to $1.2M
April 30, 2021
Forte Biosciences CEO Martin Duvall's 2018 pay falls 54% to $2M
April 19, 2019
About Forte Biosciences
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247
- Phone(310) 618-6994
- Fiscal year endDecember 31
- Former names
- Tocagen IncUntil June 14, 2020
Source: SEC filings on December 31, 2024, April 29, 2022, April 30, 2021, April 19, 2019, and April 30, 2018.